Inhibrx Biosciences (INBX) Short Positioning
Inhibrx Biosciences, Inc. (INBX) has emerged as a notable ticker on the Fintel Short Squeeze Leaderboard, currently holding a score of 76. This metric is derived from a quantitative analysis of short interest, borrow availability, and price action. For traders, this indicates that a significant portion of the float is currently held by short sellers. Given the biotech sector's propensity for high volatility, the current short positioning suggests that any positive clinical or regulatory news could force a rapid short squeeze as participants rush to cover their positions.
Signal data sourced from Fintel. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.